Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies.

ABSTRACT:

SUBMITTER: Wright LS 

PROVIDER: S-EPMC4931721 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature